SOFINNOVA VENTURE PARTNERS VI L P

10% owner at Orexigen Therapeutics, Inc. · on record since Apr 25, 2007
10% owner at Anthera Pharmaceuticals Inc · on record since Feb 23, 2010
10% owner at Ocera Therapeutics, Inc. · on record since Jul 17, 2013
10% owner at MARINUS PHARMACEUTICALS, INC. · on record since Jul 31, 2014

Insider trading activity of SOFINNOVA VENTURE PARTNERS VI L P

Transactions on record: 31; since May 3, 2007

Open-market buys: 0

Open-market sells: 0

Companies traded: 2; last filing Mar 8, 2010

Figures computed from official regulatory filings — .

Companies where SOFINNOVA VENTURE PARTNERS VI L P has traded

Anthera Pharmaceuticals Inc13 tx · $11.9M · Mar 8, 2010
Orexigen Therapeutics, Inc.18 tx · May 3, 2007

Track record of SOFINNOVA VENTURE PARTNERS VI L P

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of SOFINNOVA VENTURE PARTNERS VI L P

Co-insiders of SOFINNOVA VENTURE PARTNERS VI L P

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	Other	236,032	5.25	$1.2M	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	OtherD (derivative)	-384,175	—	n/a (No price was disclosed in the filing)	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	AwardD (derivative)	42,167	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	Other	384,175	—	n/a (No price was disclosed in the filing)	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	Other	828,323	—	n/a (No price was disclosed in the filing)	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	AwardD (derivative)	63,251	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	OtherD (derivative)	-864,855	—	n/a (No price was disclosed in the filing)	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	Award	420,166	7.00	$2.9M	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	OtherD (derivative)	-828,323	—	n/a (No price was disclosed in the filing)	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	Award	744,496	6.58	$4.9M	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	Other	350,056	5.25	$1.8M	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	Other	155,127	6.58	$1M	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	Other	864,855	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	Other	565,253	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	Other	141,712	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	Other	9,750	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	OtherD (derivative)	-1,130,507	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	OtherD (derivative)	-283,424	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	Other	715,256	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	Other	1,049,042	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	Other	7,705	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	OtherD (derivative)	-28,600	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	OtherD (derivative)	-1,430,512	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	Other	207,844	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	Other	14,300	—	n/a (No price was disclosed in the filing)	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	Other	236,032	5.25	$1.2M	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	OtherD (derivative)	-384,175	—	n/a (No price was disclosed in the filing)	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	AwardD (derivative)	42,167	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	Other	384,175	—	n/a (No price was disclosed in the filing)	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	Other	828,323	—	n/a (No price was disclosed in the filing)	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	AwardD (derivative)	63,251	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	OtherD (derivative)	-864,855	—	n/a (No price was disclosed in the filing)	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	Award	420,166	7.00	$2.9M	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	OtherD (derivative)	-828,323	—	n/a (No price was disclosed in the filing)	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	Award	744,496	6.58	$4.9M	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	Other	350,056	5.25	$1.8M	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	Other	155,127	6.58	$1M	SEC
Anthera Pharmaceuticals IncListing on record	Mar 8, 2010	Other	864,855	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	Other	565,253	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	Other	141,712	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	Other	9,750	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	OtherD (derivative)	-1,130,507	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	OtherD (derivative)	-283,424	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	Other	715,256	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	Other	1,049,042	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	Other	7,705	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	OtherD (derivative)	-28,600	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	OtherD (derivative)	-1,430,512	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	Other	207,844	—	n/a (No price was disclosed in the filing)	SEC
Orexigen Therapeutics, Inc.Listing unverified	May 3, 2007	Other	14,300	—	n/a (No price was disclosed in the filing)	SEC